IFN-DLI for Relapsed Acute Leukemia After Allo-SCT
Clinical trial NCT02331706 · COMPLETED
Trial details
- NCT number
- NCT02331706
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-11-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.